Collegium Pharmaceutical
COLL
#6617
Rank
NZ$1.40 B
Marketcap
NZ$45.19
Share price
-1.94%
Change (1 day)
-43.79%
Change (1 year)

Earnings for Collegium Pharmaceutical (COLL)

Earnings in 2026 (TTM): NZ$0.20 Billion

According to Collegium Pharmaceutical 's latest financial reports the company's current earnings are NZ$0.81 Billion. In 2025 the company made an earning of NZ$0.31 Billion, an increase over its 2024 earnings that were of NZ$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Collegium Pharmaceutical from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.20 B-35.24%
2025 NZ$0.31 B1.38%
2024 NZ$0.31 B8.47%
2023 NZ$0.29 B362.88%
2022 NZ$62.82 M94.82%
2021 NZ$32.24 M-68.76%
2020 NZ$0.10 B-358.85%
2019 -NZ$39.88 Million14.82%
2018 -NZ$34.73 Million-74.68%
2017 -NZ$0.14 Billion-20.23%
2016 -NZ$0.18 Billion250.85%
2015 -NZ$49.02 Million51.81%
2014 -NZ$32.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
United Therapeutics
UTHR
NZ$2.77 B 1,179.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-NZ$27.47 Million-112.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
NZ$0.93 B 331.56%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
KemPharm
KMPH
-NZ$76.6 Million-135.28%๐Ÿ‡บ๐Ÿ‡ธ USA